Sphere Fluidics – Parkwalk closes further funding round
We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously. Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D… Read More
Fluidic Analytics – University of Cambridge Enterprise Fund IV and Parkwalk investment
Parkwalk have recently closed an investment in Fluidic Analytics for the University of Cambridge Enterprise Fund IV and Parkwalk Funds. Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By… Read More
Parkwalk portfolio company CCMOSS – acquired by ams AG to become world leader in gas and infrared sensing
ams AG (SIX: AMS), a leading worldwide manufacturer of high performance sensor and analog solutions, has acquired 100% of the shares in Cambridge CMOS Sensors Ltd (CCS), the technology leader in micro hotplate structures for gas sensing and… Read More
DefiniGEN – Parkwalk closes follow on investment
Parkwalk closes DefiniGen investment for the University of Cambridge Enterprise Fund IV and Parkwalk Funds DefiniGEN, a spin-out from the University of Cambridge Regenerative Medicine Department at Addenbrooke’s Hospital, have created a stem cell technology to provide human… Read More
Sphere Fluidics – University of Cambridge Enterprise Fund III closes further funding round
We have closed an investment, in a $7m funding round, in Sphere Fluidics for the University of Cambridge Enterprise Fund III. This follows the UCEFs I and II investing previously. The investment round has been led by an Asian corporate investor Sphere Fluidics… Read More
AQDOT – Follow on Investment
We have recently made a follow-on investment into Aqdot on behalf of the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III. Aqdot is a spin-out from the Department of Chemistry at the University of Cambridge and was… Read More
CCMOSS – Parkwalk closes further funding round
We have recently made an investment in Cambridge CMOS Sensors for the Parkwalk Opportunities EIS Fund and the University of Cambridge Enterprise Fund III.. This follows predecessor funds investing in 2012 and 2013. Cambridge CMOS Sensors is a leading… Read More
FT: Fluidic Analytics develops tools to warn of diseases
Imagine if a simple pinprick blood test could tell if you were in the early stages of Alzheimer’s or heart disease. This is the vision behind Fluidic Analytics, spun out of Cambridge university, which is developing tools to… Read More
Fluidic Analytics – University of Cambridge Enterprise Fund II and Parkwalk investment
Parkwalk have recently closed an investment in Fluidic Analytics for the University of Cambridge Enterprise Fund II and Parkwalk Funds. Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By combining… Read More
AQDOT – Follow on Investment
We have recently made a follow-on investment into AQDOT on behalf of the University of Cambridge Enterprise Fund II and the Parkwalk UK Technology Fund V. AQDOT‘s technology allows for an energy- and raw material-efficient way of manufacturing… Read More
DefiniGEN Joins EBiSC Consortium
DefiniGEN (an investment in the University of Cambridge Enterprise Funds I & II), a leading provider of stem cell life science products and services has joined the European Bank for induced pluripotent stem cells (EBiSC) consortium. The consortium… Read More
RoadMap – University of Cambridge Enterprise Fund II investment
We have recently made an investment in RoadMap for the University of Cambridge Enterprise Fund II in a first round of financing of £515k. It is envisioned that a further financing round will be required in 12 months…. Read More
Jukedeck – University of Cambridge Enterprise Fund II investment
We have closed an investment in Jukedeck for the University of Cambridge Enterprise Fund II. Jukedeck provides unique, copyright-free music at the touch of a button. The product is based on a program that generates unique music algorithmically, built on three… Read More
Vocal IQ – University of Cambridge Enterprise Fund II investment
We have closed an investment, in a seed financing round of £750,000 in VocalIQ for the University of Cambridge Enterprise Fund II. The round was led by Amadeus Capital Partners. Cambridge Enterprise, the commercialisation arm of the University of Cambridge, is also investing…. Read More
Sphere Fluidics – Parkwalk closes further funding round
We have closed an investment, in the first tranche of a financing round of up to £2m, in Sphere Fluidics for the University of Cambridge Enterprise Fund II and the final investment for Parkwalk Fund IV. This follows the UoCEF I… Read More
CCMOSS – Parkwalk closes further funding round
We have recently made an investment in Cambridge CMOS Sensors for the UK Tech Fund V and a Parkwalk Syndicate. This follows predecessor funds investing in 2012 and 2013. Cambridge CMOS Sensors are a leading manufacturer of sensor solutions… Read More
Cambridge Enterprise
A huge thank you to all the team at Cambridge Enterprise for an excellent University of Cambridge Enterprise Fund investor evening yesterday at Emmanuel College. Investee companies presenting included: Aqdot (highlighted in the FT yesterday) Cambridge CMOS Sensors DefiniGEN… Read More
DefiniGEN
Parkwalk closes DefiniGEN investment for the University of Cambridge Enterprise Fund II DefiniGEN provides human liver cells for preclinical drug development and disease modelling applications using human Induced Pluripotent Stem Cell hIPSC technology. The Company provides human cells… Read More
